Reports

Ideas That Generate Results

1. Analyst View

2. Research Methodology

3. Global Protein Therapeutics Market
     3.1 Protein Therapeutics Market vs Pharmaceutical Market
     3.2 Current and Future Market Analysis to 2020
            3.2.1 Market Segmentation
            3.2.2 Market Dynamics
                       3.2.2.1 Drivers
                                     3.2.2.1.1 Increasing Healthcare Expenditure in the Emerging Markets
                                     3.2.2.1.2 Government Initiatives to Improve the Healthcare Services
                                     3.2.2.1.3 Rising Prevalence of Chronic Diseases
                                     3.2.2.1.4 Growing Geriatric Population
                       3.2.2.2 Challenges
                                     3.2.2.2.1 High Cost of Production and Treatment
                                     3.2.2.2.2 Competition from Biosimilars
                                     3.2.2.2.3 Patent Expiry of Blockbuster Drugs
                       3.2.2.3 Opportunities
                                     3.2.2.3.1 Potential for Bispecific Monoclonal Antibodies
                                     3.2.2.3.2 Unmet Medical Needs in the Developing Countries

4. Industry Performance
     4.1 Monoclonal Antibodies (mAbs)
            4.1.1 Scientific Insight
            4.1.2 Current and Future Market Analysis to 2020
            4.1.3 By Application
            4.1.4 Key Geographical Markets
            4.1.5 Key Players and Drugs
            4.1.6 Recent Developments
     4.2 Erythropoietin (EPO)
            4.2.1 Scientific Insight
            4.2.2 Current and Future Market Analysis to 2020
            4.2.3 By Application
            4.2.4 Key Geographical Markets
            4.2.5 Key Players and Drugs
            4.2.6 Recent Developments
     4.3 Insulin
            4.3.1 Scientific Insight
            4.3.2 Current and Future Market Analysis to 2020
            4.3.3 By Application
            4.3.4 Key Geographical Markets
            4.3.5 Key Players and Drugs
            4.3.6 Recent Developments
     4.4 Interferon (IFN)
            4.4.1 Scientific Insight
            4.4.2 Current and Future Market Analysis to 2020
            4.4.3 By Application
            4.4.4 Key Geographical Markets
            4.4.5 Key Players and Drugs
            4.4.6 Recent Developments
     4.5 Human Growth Hormone (HGH)
            4.5.1 Scientific Insight
            4.5.2 Current and Future Market Analysis to 2020
            4.5.3 Key Geographical Markets
            4.5.4 Key Players and Drugs
            4.5.5 Recent Developments
     4.6 Blood Clotting Factor
            4.6.1 Scientific Insight
            4.6.2 Current and Future Market Analysis to 2020
            4.6.3 By Factor Type
            4.6.4 Key Geographical Markets
            4.6.5 Key Players and Drugs
            4.6.6 Recent Developments
     4.7 Follicle Stimulating Hormone (FSH)
            4.7.1 Scientific Insight
            4.7.2 Current and Future Market Analysis to 2020
            4.7.3 Key Players and Drugs
            4.7.4 Recent Developments
     4.8 Granulocyte Colony Stimulating Factor (G-CSF)
            4.8.1 Scientific Insight
            4.8.2 Current and Future Market Analysis to 2020
            4.8.3 Key Geographical Markets
            4.8.4 Key Players and Drugs
            4.8.5 Recent Developments

5. Advanced Phase Drugs Analysis

6. Emerging Market Trends
     6.1 Gaining Momentum: Strategic Activities among Players to Develop Novel Treatments
     6.2 Effective Delivery Methods: Improving the Reach of Therapies
     6.3 Players Investing Heavily in Multiple Sclerosis and Cancer Therapeutics
     6.4 Increasing Focus on Development of Biobetters

7. Porters Five Forces Analysis

8. Key Players
     8.1 Johnson & Johnson
     8.2 Biogen Idec Inc.
     8.3 Eli Lilly & Company
     8.4 Sanofi-Aventis
     8.5 Merck Serono S.A.
     8.6 Roche Group
     8.7 Amgen Inc.
     8.8 Pfizer
     8.9 Abbott Laboratories
     8.10 Novo Nordisk